P-167 - Efficacy and tolerance of XELOX plus bevacizumab as first line therapy in Moroccan patients with metastatic colorectal cancer
Autor: | Mahfoud, Tarik, Khmamouche, Mohamed Réda, Tanz, Rachid, Errihani, Hassan, Ichou, Mohamed |
---|---|
Zdroj: | In Annals of Oncology June 2017 28 Supplement 3:iii62-iii62 |
Databáze: | ScienceDirect |
Externí odkaz: |